Cellular Therapy Philadelphia

Chronic obstructive pulmonary disease (COPD) sufferers in the City of Brotherly Love can now receive treatment without leaving the state of Pennsylvania. With a relaxing train ride or at under 5-hours’ drive from Philadelphia, Pittsburgh offers cutting-edge medical treatment at prestigious healthcare facilities, as well as the opportunity to explore the city’s labor and steel industry history, fine restaurants and lodging, and and many other activities in the city where three rivers meet.  Come for the outstanding medical treatment offered in Pittsburgh, and stay on for a short vacation in a beautiful and historic Midwestern city.

Treating Lung Disease with Cells

The Lung Institute state-of-the-art clinics harvest cells, the body’s natural healing system, from a patient’s own blood, fat or bone marrow and reintroduce them into the body, directing their healing ability toward lung tissue. This high dose of cells promote healing and helps patients breathe more easily.

The Lung Institute uses autologous cells, derived from the patient’s own body for the bone marrow and the venous (blood-derived) stem cell procedures. Cells are extracted, isolated and immediately introduced back into the body where they replicate into healthy cells specialized to promote healing. All our stem cell procedures have shown anti-inflammatory properties beneficial to patients with lung disease.

The city of Pittsburgh leads lung disease research with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Pittsburgh Lung Institute clinic treats interstitial lung disease and other serious lung disorders including COPD, emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

 

How Does the Lung Institute use Cells?

The Lung Institute offers cellular therapys for many of the major pulmonary conditions, including chronic obstructive pulmonary disorder (COPD), emphysemachronic bronchitispulmonary fibrosis and interstitial lung disease. The cells used by the Lung Institute are autologous, which means they come from the patient’s own body. The cells are extracted from the patient’s own  blood. Cells have the capacity to form many types of differentiated cells, so when the cells are returned to the patient, they will target the damaged tissue, which leads to improved lung function in patients with a chronic lung disease. Our minimally invasive, outpatient cellular therapy are changing lives by helping patients breathe easier.

Why Choose the Lung Institute?

At the Lung Institute, we recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases such as chronic obstructive pulmonary disease (COPD)pulmonary fibrosis, or interstitial lung disease. By harnessing the body’s innate healing capacity, we have developed revolutionary, minimally invasive cellular therapies to help treat lung disease. Our goal is to help patients breathe easier, improve their quality of life and provide hope.

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative regenerative medicine solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.